DeepMed Research

PUR-118

Generic Name: PUR-118

Clinical Trials

Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers

Phase 1

Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Drug: PUR118

First Posted Date: 2012-09-24

Last Posted Date: 2013-07-19

Lead Sponsor: Pulmatrix Inc.

Target Recruit Count: 24

Registration Number: NCT01690949

Locations: 🇩🇪
Fraunhofer Institut fur Toxicologie und Experimentelle Medicine (ITEM), Hannover, Germany

A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

Phase 1

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: PUR118

First Posted Date: 2012-03-02

Last Posted Date: 2013-07-19

Lead Sponsor: Pulmatrix Inc.

Target Recruit Count: 10

Registration Number: NCT01543191

Locations: 🇬🇧
Celerion, Belfast, Northern Ireland, United Kingdom

Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118

Phase 1

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: PUR118

First Posted Date: 2011-04-12

Last Posted Date: 2012-09-07

Lead Sponsor: Pulmatrix Inc.

Target Recruit Count: 90

Registration Number: NCT01333904

Locations: 🇬🇧
Quotient Bioresearch, Nottingham, United Kingdom

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy